No paracetamol, painkillers recommended after Covaxin jab: Bharat Biotech
Medication is recommended only after consultation with a physician, the vaccine maker said
Author
Indian pharma industry estimated to grow nine to 11 per cent in 2021-22: ICRA
The normalisation of the base and pricing pressures in the US market were the major reasons for slowing growth momentum in Q2…
Covovax better booster for Covishield-vaccinated people: Shahid Jameel
Dr Jameel, the former head of the advisery group to the Indian SARS-COV-2 Genomics Consortia (INSACOG), said there is no data for…
Natco Pharma plans to launch Molnupiravir capsules this week
The company has received approval for Molnupiravir capsules (200 mg), which would be sold under brand name Molnunat in the country
Biological E aims to produce 100 million doses/month of Corbevax from Feb 2022
Soon, the company plans to deliver more than one billion additional doses globally
Granules India gets US FDA nod for generic Prazosin Hydrochloride capsules
These capsules are bioequivalent to the reference listed drug product, Mini plus capsules 1mg, 2mg and 5mg of Pfizer Inc
Lupin gets tentative US FDA nod for generic tablets to treat high BP
These are generic equivalent of Edarbi tablets, 40 mg and 80 mg of Arbor Pharmaceuticals, LW
Torrent Pharma recalls 27,000 bottles of BP lowering medicine in the US
According to the US health regulator, the company is recalling the affected lot due to it being "Superpotent;…
Third wave of COVID in India likely to peak in early Feb: Study
The researchers at the Indian Institute of Technology Kanpur modelled the daily data of cases from countries such as the US, UK,…
DCGI seeks more data from SII over its application seeking emergency authorisation for Covovax
Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for…